SCHEMBL30037005

SCHEMBL30037005

C=CC(O)c1ccc(C)c(F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.41
AKR1C2 P52895 1/20 0.41
ALDH1A1 P00352 7/20 0.38
LMNA P02545 5/20 0.37
KMT2A Q03164 4/20 0.37
MEN1 O00255 3/20 0.37
HRH3 Q9Y5N1 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
POLB P06746 2/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HTT P42858 3/20 0.35
TP53 P04637 1/20 0.35
GPR139 Q6DWJ6 2/20 0.34
OPRM1 P35372 1/20 0.34
OPRD1 P41143 1/20 0.34
OPRK1 P41145 1/20 0.34
OPRL1 P41146 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
TRPA1 O75762 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25551751 1.00 AKR1C3 (0.41) AKR1C3AKR1C2ALDH1A1LMNAKMT2A
SCHEMBL16951664 0.81 AKR1C3 (0.40) AKR1C3AKR1C2ALDH1A1LMNAKMT2A
SCHEMBL18473682 0.78 TRPA1 (0.33) LMNAKMT2AMEN1HRH3TP53
SCHEMBL20488728 0.76 AKR1C3 (0.49) AKR1C3AKR1C2ALDH1A1LMNAKMT2A
SCHEMBL1926385 0.76 AKR1C3 (0.49) AKR1C3AKR1C2ALDH1A1LMNAKMT2A
SCHEMBL4905102 0.76 ORAI1 (0.42) ALDH1A1LMNAKMT2AMEN1HRH3
SCHEMBL3885072 0.76 ORAI1 (0.42) ALDH1A1LMNAHRH3SMN1; SMN2HDAC1
SCHEMBL10178376 0.75 AKR1C3 (0.37) AKR1C3AKR1C2ALDH1A1LMNAKMT2A
SCHEMBL20150760 0.75 AKR1C3 (0.47) AKR1C3AKR1C2ALDH1A1LMNAKMT2A
SCHEMBL4596488 0.74 TSHR (0.38) NPSR1TRPA1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115515940-A Inhibitors of receptor interacting protein kinase I for the treatment of disease 德州大学系统董事会 2022-12-23 CN disclosed